Literature DB >> 16133540

Progressive accumulation of ubiquitin and disappearance of alpha-synuclein epitope in multiple system atrophy-associated glial cytoplasmic inclusions: triple fluorescence study combined with Gallyas-Braak method.

Masaki Sakamoto1, Toshiki Uchihara, Ayako Nakamura, Toshio Mizutani, Hidehiro Mizusawa.   

Abstract

Alpha-synuclein (alphaS) and ubiquitin (Ub) are shared constituents of glial cytoplasmic inclusions (GCIs) and Lewy bodies (LBs), both composed of fibrillary structures. Staining profiles of GCIs were investigated with triple immunofluorescence involving immunostaining for alphaS and Ub, both amplified with catalyzed reporter deposition, and a fluorochrome, thiazin red (TR) that has an affinity to fibrillary structures. After observation for the triple-fluorescent images, the sections were subsequently stained with the Gallyas-Braak method. Sections of putamen, cerebellar white matter and motor cortex from patients suffering from multiple system atrophy (MSA) with varying duration of the disease (4-15 years) were quantified for these staining profiles of Gallyas-positive GCIs. Although most of GCIs were positive for Ub and variably positive for alphaS, they were consistently negative for TR. The result was opposite in LBs in Lewy body disease with variable affinity to TR, suggesting that the construction of GCIs is different from that of LBs. These four staining features (alphaS, Ub, TR and Gallyas) alone failed to exhibit apparent correlation with disease duration, lesion site or severity of degeneration as reported previously. The fraction of alphaS-negative and Ub-positive GCIs, however, linearly increased along the disease progression, while that of alphaS-positive and Ub-negative GCIs decreased in contrast. This reciprocal change suggests that alphaS immunoreactivity in GCIs is being replaced by Ub immunoreactivity during the disease progression, which resulted in the ultimate predominance of alphaS-negative and Ub-positive GCIs in the most advanced case. Interestingly, this predominance of alphaS-negative and Ub-positive GCIs was a feature of motor cortex, where degeneration usually remains mild in spite of robust appearance of Gallyas-positive GCIs. Another fraction, alphaS-positive and Ub-positive GCIs were frequent in cerebellar white matter, suggesting that GCI evolution is heterogeneous and dependent also on area examined. Progressive accumulation of Ub with concomitant disappearance of alphaS epitope and their colocalization, partly shared with LBs, may represent a process of GCI formation, possibly linked to an aspect of degeneration in MSA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16133540     DOI: 10.1007/s00401-005-1066-9

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  4 in total

1.  Progression of alpha-synuclein pathology in multiple system atrophy of the cerebellar type.

Authors:  J Brettschneider; D J Irwin; S Boluda; M D Byrne; L Fang; E B Lee; J L Robinson; E Suh; V M Van Deerlin; J B Toledo; M Grossman; H Hurtig; R Dengler; S Petri; V M-Y Lee; J Q Trojanowski
Journal:  Neuropathol Appl Neurobiol       Date:  2016-10-18       Impact factor: 8.090

2.  Neuropathology of Multiple System Atrophy, a Glioneuronal Degenerative Disease.

Authors:  Koichi Wakabayashi; Yasuo Miki; Kunikazu Tanji; Fumiaki Mori
Journal:  Cerebellum       Date:  2022-04-26       Impact factor: 3.847

3.  Converging Patterns of α-Synuclein Pathology in Multiple System Atrophy.

Authors:  Johannes Brettschneider; EunRan Suh; John L Robinson; Lubin Fang; Edward B Lee; David J Irwin; Murray Grossman; Vivianna M Van Deerlin; Virginia M-Y Lee; John Q Trojanowski
Journal:  J Neuropathol Exp Neurol       Date:  2018-11-01       Impact factor: 3.685

4.  An autopsy report on multiple system atrophy diagnosed immunohistochemically despite severe ischaemic damage: a new approach for investigation of medical practice associated deaths in Japan.

Authors:  M Nakajima; H Kojima; Y Takazawa; N Yahagi; K Harada; K Takahashi; K Unuma; K Yoshida
Journal:  J Clin Pathol       Date:  2009-11       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.